SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in CADL — Candel Therapeutics, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in CADL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$553,567
-$222,788 QoQ
Shares Held
112,973
-17.8% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Derivatives in CADL
reported options exposure · as of Mar 31, 2026CallValue
$813,890
CallShares
166,100
PutValue
$691,880
PutShares
141,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. CADL ranks #227 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in CADL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $813,890 | 166,100 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $553,567 | 112,973 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $691,880 | 141,200 | Put | Other | 2026-05-15 | |
| 2025-12-31 | $776,355 | 137,408 | Shares | Other | 2026-02-17 | |
| 2025-12-31 | $412,450 | 73,000 | Put | Other | 2026-02-17 | |
| 2025-12-31 | $172,325 | 30,500 | Call | Other | 2026-02-17 | |
| 2025-09-30 | $477,870 | 93,700 | Put | Other | 2025-11-14 | |
| 2025-09-30 | $401,880 | 78,800 | Call | Other | 2025-11-14 | |
| 2025-09-30 | $1,141,487 | 223,821 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $834,394 | 164,900 | Put | Other | 2025-08-14 | |
| 2025-06-30 | $596,574 | 117,900 | Call | Other | 2025-08-14 | |
| 2025-06-30 | $1,787,687 | 353,298 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,430,015 | 253,100 | Put | Other | 2025-05-14 | |
| 2025-03-31 | $1,184,805 | 209,700 | Call | Other | 2025-05-14 | |
| 2025-03-31 | $1,362,638 | 241,175 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $5,741,820 | 661,500 | Call | Other | 2025-02-14 | |
| 2024-12-31 | $3,213,336 | 370,200 | Put | Other | 2025-02-14 | |
| 2024-12-31 | $2,555,765 | 294,443 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $938,703 | 135,455 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $163,548 | 23,600 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $446,292 | 64,400 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $258,540 | 41,700 | Put | Defined | 2024-08-15 | |
| 2024-06-30 | $140,740 | 22,700 | Call | Defined | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||